DECIPHERA Trademark

Trademark Overview


On Tuesday, April 18, 2023, a trademark application was filed for DECIPHERA with the United States Patent and Trademark Office. The USPTO has given the DECIPHERA trademark a serial number of 97894977. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 20, 2024. This trademark is owned by Deciphera Pharmaceuticals, LLC. The DECIPHERA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
deciphera

General Information


Serial Number97894977
Word MarkDECIPHERA
Filing DateTuesday, April 18, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and Servicespharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Goods and Servicesmedical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Goods and Servicespharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 14, 2023
Primary Code005
First Use Anywhere DateSaturday, May 16, 2020
First Use In Commerce DateWednesday, May 20, 2020

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 14, 2023
Primary Code042
First Use Anywhere DateFriday, October 31, 2003
First Use In Commerce DateFriday, October 31, 2003

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 14, 2023
Primary Code044
First Use Anywhere DateSaturday, May 16, 2020
First Use In Commerce DateWednesday, May 20, 2020

Trademark Owner History


Party NameDeciphera Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Party NameDeciphera Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Friday, February 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, February 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, January 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 12, 2024ASSIGNED TO EXAMINER
Sunday, May 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 21, 2023NEW APPLICATION ENTERED